Status:
COMPLETED
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Clostridium Enterocolitis
Pseudomembranous Colitis
Eligibility:
All Genders
Brief Summary
The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and a...
Detailed Description
Clostridium difficile is the leading cause of nosocomial diarrheal disease associated with antibiotic therapy. This is a debilitating condition with substantial morbidity and mortality that may be aro...
Eligibility Criteria
Inclusion
- All patients at the Houston VA with documented C. difficile infection
Exclusion
- None
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00304408
Start Date
January 1 2005
End Date
January 1 2008
Last Update
September 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E. Debakey VA Medical Center
Houston, Texas, United States, 77030